SPDR S&P Pharmaceuticals ETF (XPH) News Today → What’s Really Next for America… (From Porter & Company) (Ad) Free XPH Stock Alerts $41.02 +0.46 (+1.13%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 30, 2024 | finance.yahoo.comSPDR S&P Pharmaceuticals ETF (XPH)March 28, 2024 | seekingalpha.comXPH: A More Balanced Way To Get Exposure To PharmaceuticalsFebruary 16, 2024 | wsj.comSPDR S&P Pharmaceuticals ETFFebruary 5, 2024 | marketbeat.comPharmaceutical Stocks - Best Pharmaceutical Stocks to Buy (XPH)Along with biotechnology and biotech companies, the pharma industry is a major part of the overall healthcare market. Pharmaceutical companies include some of the biggest stock gainers and some of the best growth stocks on the market. The pharmaceutical market has many amazing stocks to watch. The pharma industry may also be a good investment for those looking for dividend stocks since so many of the largest pharmaceutical companies pay a dividend to its shareholders. Though the industry has plenty of potential for growth, investors should also be aware that pharma stocks—especially smaller startups—can be risky. Investors buying pharma stocks should make sure to do their research and only invest in pharma stocks as part of a diversified portfolio.February 5, 2024 | usatoday.comS&P 500 (SPX) today: Catalent Inc is a top mover, up 10%December 23, 2023 | benzinga.comSPDR S&P Pharmaceuticals ETF (ARCA:XPH), Quotes and News SummaryDecember 18, 2023 | msn.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1744November 6, 2023 | marketwatch.comWhy the S&P 500 ETF’s rare triple ‘gap ups’ isn’t a buy signalOctober 29, 2023 | investing.comXPH ETF Stock Price HistoryOctober 20, 2023 | thestreet.comETF Watch: Fortitude, Not Fashion Wins OutSeptember 18, 2023 | msn.comSPDR Portfolio Mid Cap ETF declares quarterly distribution of $0.1758September 1, 2023 | marketbeat.comHow Much Pain Will Lower Medicare Prices Cause for Pharma Stocks? (XPH)Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.June 25, 2023 | msn.comWhat is behind big pharma's underperformance?June 21, 2023 | msn.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1235May 31, 2023 | markets.businessinsider.comSPY ETF Gains 11% YTD: Technical Indicators Signal Further UpsideApril 12, 2023 | marketwatch.comWhen Spdr S&p Pharmaceuticals ($XPH) Moves Investors should ListenMarch 22, 2023 | seekingalpha.comXPH SPDR S&P Pharmaceuticals ETFJanuary 3, 2023 | seekingalpha.comSPYV: How Microsoft And Amazon Changed The S&P 500 Value IndexDecember 27, 2022 | seekingalpha.comEli Lilly: Right Industry, Wrong PriceDecember 19, 2022 | msn.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1940December 16, 2022 | msn.comSPDR S&P 500 ESG ETF declares quarterly distribution of $0.1728November 13, 2022 | seekingalpha.comXPH: U.S. Pharmaceuticals Stocks Are Probably Fairly Valued, Cyclically UnattractiveNovember 2, 2022 | msn.comChevron, Uber Technologies, And A Way To 'Bet Against The Big Guys' Are CNBC's 'Final Trades'October 1, 2022 | seekingalpha.comMDYG SPDR S&P 400 Mid Cap Growth ETFSeptember 21, 2022 | seekingalpha.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1320September 7, 2022 | thestreet.comDrug ETFs Likely Winners of Health LawSeptember 5, 2022 | thestreet.comObamacare Still Sickly, After All These YearsJuly 2, 2022 | thestreet.comSPDR S&P Pharmaceuticals ETF NewsMay 24, 2022 | theglobeandmail.comGordon Pape’s mailbag: Pharma ETFs, tax losses, undeclared capital gains and other investing questionsMay 3, 2022 | realmoney.thestreet.comIn a Sick Market, Can Pharmas Help?April 27, 2022 | nasdaq.com12.8% of XPH Holdings Seeing Recent Insider BuysMarch 18, 2022 | nasdaq.comInsiders Buy the Holdings of XPH ETFMarch 5, 2022 | seekingalpha.comViatris stands out amid selloff in generic drugmakersNovember 15, 2021 | nasdaq.comIs SPDRSP PHARMA (XPH) a Strong ETF Right Now?November 4, 2021 | nasdaq.comThursday's ETF with Unusual Volume: XPH Get SPDR S&P Pharmaceuticals ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for XPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now XPH Media Mentions By Week XPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XPH News Sentiment▼1.000.96▲Average News Sentiment XPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XPH Articles This Week▼00▲XPH Articles Average Week Get SPDR S&P Pharmaceuticals ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for XPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Invesco S&P SmallCap Health Care ETF News Today Invesco Biotechnology & Genome ETF News Today Simplify Health Care ETF News Today ProShares Ultra Nasdaq Biotechnology News Today Principal Healthcare Innovators ETF News Today Invesco Nasdaq Biotechnology ETF News Today Langar Global HealthTech ETF News Today VanEck Biotech ETF News Today VanEck Pharmaceutical ETF News Today iShares U.S. Pharmaceuticals ETF News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEARCA:XPH) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
